Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Chiorean · SciRah

Researcher profile · Semantic Scholar

M. Chiorean

Share profile

M. Chiorean — researcher profile on SciRah

h-index: 24
Works: 174
Citations: 2,884

Most-cited papers

Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
W. Sandborn, S. Vermeire, L. Peyrin-Biroulet, M. Dubinsky +16 more
2023The Lancet282 citations Open access
Semantic Scholar
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis.
W. Sandborn, L. Peyrin-Biroulet, Jin-kun Zhang, M. Chiorean +8 more
2019Gastroenterology209 citations Open access
Semantic Scholar
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
S. Vermeire, M. Chiorean, J. Panés, L. Peyrin-Biroulet +7 more
2021Journal of Crohn's & Colitis100 citations Open access
Semantic Scholar
Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease
Elisa K Boden, D. Shows, M. Chiorean, J. Lord
2018Digestive Diseases and Sciences55 citations
Semantic Scholar
Clinician’s Guide to Using Ozanimod for the Treatment of Ulcerative Colitis
B. Sands, S. Schreiber, I. Blumenstein, M. Chiorean +2 more
2023Journal of Crohn's & Colitis49 citations Open access
Semantic Scholar
Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group.
B. Shen, G. Kochhar, U. Navaneethan, R. Cross +30 more
2021The Lancet Gastroenterology and Hepatology47 citations
Semantic Scholar
Efficacy and Safety of Approximately 3 Years of Continuous Ozanimod in Moderately to Severely Active Ulcerative Colitis: Interim Analysis of the True North Open-label Extension
S. Danese, R. Panaccione, M. Abreu, David T. Rubin +15 more
2023Journal of Crohn's & Colitis42 citations Open access
Semantic Scholar
Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial
M. Desai, Karlee J. Ausk, Donald Brannan, R. Chhabra +27 more
2023American Journal of Gastroenterology34 citations
Semantic Scholar
A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares
P. Dulai, L. Raffals, D. Hudesman, M. Chiorean +16 more
2020Alimentary Pharmacology and Therapeutics32 citations
Semantic Scholar
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease
V. Pozdnyakova, Gregory J. Botwin, K. Sobhani, J. Prostko +46 more
2021Gastroenterology30 citations Open access
Semantic Scholar
Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection
K. Kim, M. Schwartz, O. Lin, M. Chiorean +1 more
2019Advances in Therapy23 citations Open access
Semantic Scholar
Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
R. Cross, M. Chiorean, F. Vekeman, Yong-Ling Xiao +3 more
2019PLoS ONE23 citations Open access
Semantic Scholar
Optimizing the quality of endoscopy in inflammatory bowel disease: focus on surveillance and management of colorectal dysplasia using interactive image- and video-based teaching.
T. Kaltenbach, R. Soetikno, R. Devivo, L. Laine +20 more
2017Gastrointestinal Endoscopy23 citations
Semantic Scholar
Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult To Sedate.
Hyun Seok Lee, N. Nagra, Danielle La Selva, R. Kozarek +10 more
2020Clinical Gastroenterology and Hepatology22 citations
Semantic Scholar
One year experience with computer-assisted propofol sedation for colonoscopy
O. Lin, Danielle La Selva, R. Kozarek, Deborah Tombs +10 more
2017World Journal of Gastroenterology20 citations Open access
Semantic Scholar
P632 Etrasimod induction therapy in moderately to severely active Crohn’s disease: results from a phase 2, randomised, double-blind substudy
G. D'Haens, M. Dubinsky, L. Peyrin-Biroulet, S. Danese +16 more
2023Journal of Crohn's & Colitis17 citations
Semantic Scholar
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials
S. Vermeire, B. Sands, L. Peyrin-Biroulet, G. D'Haens +16 more
2024Journal of Crohn's & Colitis15 citations Open access
Semantic Scholar
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial
A. Yarur, M. Chiorean, J. Panés, V. Jairath +5 more
2024Journal of Crohn's & Colitis12 citations Open access
Semantic Scholar
Nurse-Administered Propofol Continuous Infusion Sedation: A New Paradigm for Gastrointestinal Procedural Sedation.
O. Lin, Danielle La Selva, R. Kozarek, Wade A Weigel +8 more
2020American Journal of Gastroenterology11 citations
Semantic Scholar
Advanced neoplasia detection using chromoendoscopy and white light colonoscopy for surveillance in patients with inflammatory bowel disease
K. Kim, M. Chiorean
2020Intestinal Research10 citations Open access
Semantic Scholar
Prediction of early clinical response in patients receiving tofacitinib in the OCTAVE Induction 1 and 2 studies
C. Lees, J. Deuring, M. Chiorean, M. Daperno +5 more
2021Therapeutic Advances in Gastroenterology9 citations Open access
Semantic Scholar
Role of hospitalization for inflammatory bowel disease in the post-biologic era
Celine R. Soriano, C. R. Powell, M. Chiorean, V. Simianu
2021World Journal of Clinical Cases9 citations Open access
Semantic Scholar
Computer-Assisted Propofol Sedation for Esophagogastroduodenoscopy Is Effective, Efficient, and Safe
O. Lin, Danielle Selva, R. Kozarek, Deborah Tombs +10 more
2019Digestive Diseases and Sciences9 citations
Semantic Scholar
OP09 Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
L. Peyrin-Biroulet, J. Panés, M. Chiorean, J. Zhang +6 more
2019Journal of Crohn's & Colitis8 citations
Semantic Scholar
Day Care Attendance and Infectious Complications in Children Born to Mothers with Inflammatory Bowel Disease.
M. Long, C. Siegel, B. Abraham, M. Chiorean +1 more
2021Clinical Gastroenterology and Hepatology7 citations Open access
Semantic Scholar
DOP41 Efficacy and safety of open-label treatment with tofacitinib 10 mg twice daily in patients with ulcerative colitis with clinical response, but not remission, after 52 weeks of maintenance therapy: data from the OCTAVE studies
M. Chiorean, C. Su, K. Matsuoka, A. Orlando +7 more
2019Journal of Crohn's & Colitis7 citations
Semantic Scholar
A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective, Oral Sphingosine 1-Phosphate (S1P) Receptor Modulator, Etrasimod (APD334), in Moderate to Severe Ulcerative Colitis (UC): Results From the OASIS Study: ACG Auxiliary Award (Member)
W. Sandborn, L. Peyrin-Biroulet, L. Trokan, Jin-kun Zhang +8 more
2018American Journal of Gastroenterology7 citations
Semantic Scholar
968a: ETRASIMOD 2MG ONCE DAILY AS TREATMENT FOR MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS
W. Sandborn, S. Vermeire, L. Peyrin-Biroulet, M. Dubinsky +15 more
2022Gastroenterology6 citations
Semantic Scholar
Real-world characteristics, treatment experiences and corticosteroid utilisation of patients treated with tofacitinib for moderate to severe ulcerative colitis
M. Chiorean, J. Allegretti, Puza P. Sharma, B. Chastek +6 more
2022BMC Gastroenterology6 citations Open access
Semantic Scholar
Usefulness of Fluoroscopy for Endoscopic Balloon Dilation of Crohn’s Disease-Related Strictures
Hyun Seok Lee, M. Chiorean, Elisa K Boden, J. Lord +4 more
2021Digestive Diseases and Sciences5 citations
Semantic Scholar
1006 – Histologic Remission and Mucosal Healing in a Randomized, Placebo-Controlled, Phase 2 Study of Etrasimod in Patients with Moderately to Severely Active Ulcerative Colitis
L. Peyrin-Biroulet, J. Panés, M. Chiorean, Jin-kun Zhang +6 more
2019Gastroenterology5 citations
Semantic Scholar
Integrin α4β7 Expression Preceding and Saturation During Vedolizumab Therapy Correlate with Treatment Response in Inflammatory Bowel Disease
Elisa K Boden, D. Shows, M. Chiorean, J. Lord
20175 citations
Semantic Scholar
Economic Outcomes of Inflammatory Bowel Disease Patients Switching to a Second Anti-Tumor Necrosis Factor or Vedolizumab
M. Chiorean, A. Afzali, R. Cross, D. Macaulay +3 more
2020Crohn's & Colitis 3604 citations Open access
Semantic Scholar
Risk Factors for Rescue Therapy in Crohn’s Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up
M. Fischer, Sarah C. Campbell, C. Calley, D. Helper +2 more
2017Digestive Diseases and Sciences4 citations
Semantic Scholar
Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in OCTAVE Sustain
J. Allegretti, K. Gecse, M. Chiorean, M. Argollo +7 more
2023Journal of Gastroenterology and Hepatology3 citations Open access
Semantic Scholar
S950 Symptomology Following SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease Relative to Healthcare Workers
A. Mujukian, Gregory J. Botwin, Rashmi Kumar, B. Boland +33 more
2021American Journal of Gastroenterology3 citations
Semantic Scholar
Metal and glue: best treatment choice for gastric varices?
M. Chiorean
2019Endoscopy3 citations
Semantic Scholar
798 – Efficacy and Safety of Open-Label Treatment with Tofacitinib 10 Mg Twice Daily in Patients with Ulcerativ Ecolitis with Clinical Response, But Not Remission, After 52 Weeks of Maintenance Therapy: Data from the Octave Studies
M. Chiorean, C. Su, K. Matsuoka, A. Orlando +7 more
2019Gastroenterology3 citations Open access
Semantic Scholar
Modeling of Treatment Outcomes with Tofacitinib Maintenance Therapy in Patients with Ulcerative Colitis: A Post Hoc Analysis of Data from the OCTAVE Clinical Program
M. Chiorean, M. Daperno, C. Lees, G. Bonfanti +4 more
2023Advances in Therapy2 citations Open access
Semantic Scholar
Quality assessment in screening colonoscopy: a computer will be watching you.
M. Chiorean
2022Gastrointestinal Endoscopy2 citations Open access
Semantic Scholar
S730 Ozanimod Is an Efficacious Oral Therapy After 5-ASA Failure in Immunomodulator- and Biologic-Naive Patients With Ulcerative Colitis: Post Hoc Analysis From True North
Bruce E. Sands, A. Dignass, P. Irving, M. Chiorean +7 more
2022Gastroenterology & hepatology2 citations
Semantic Scholar
Nurse-Administered Propofol Continuous Infusion Sedation: A New Paradigm for Gastrointestinal Procedural Sedation.
O. Lin, Danielle La Selva, R. Kozarek, Wade A Weigel +8 more
2021American Journal of Gastroenterology2 citations
Semantic Scholar
S741 Psychological Distress During a Global Pandemic: Prevalence and Risk Factors in a National Cohort of Inflammatory Bowel Disease (IBD) Patients
Erica R. Cohen, Gregory J. Botwin, G. Melmed, Dermot T. McGovern +30 more
2021American Journal of Gastroenterology2 citations
Semantic Scholar
764 Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
M. Chiorean, S. Vermeire, J. Panés, L. Peyrin-Biroulet +7 more
2019American Journal of Gastroenterology2 citations
Semantic Scholar
Tu1745 – Correlation of Fecal Calprotectin and C-Reactive Protein Concentrations with Clinical Outcomes and Endoscopic Disease Activity in Patients with Ulcerative Colitis Receiving Induction Therapy with Etrasimod
A. Yarur, V. Jairath, Jin-kun Zhang, J. Panés +6 more
2019Gastroenterology2 citations Open access
Semantic Scholar
Improvement in Physicianʼs Global Assessment Within 2 Weeks in Patients With Ulcerative Colitis Treated With Tofacitinib
M. Chiorean, D. Rubin, M. Lowenberg, J. Gisbert +6 more
2018American Journal of Gastroenterology2 citations
Semantic Scholar
Management of Patients With Refractory Ulcerative Proctitis.
M. Chiorean
2025Gastroenterology & hepatology1 citations
Semantic Scholar
P773 Extended induction in the True North open-label extension study: clinical outcomes of ~2 years of ozanimod treatment
David T. Rubin, J. Colombel, M. Chiorean, Subrata Ghosh +6 more
2023Journal of Crohn's & Colitis1 citations
Semantic Scholar
P715 Achievement and maintenance of endoscopic, histologic, and combined outcomes after extended induction in Week 10 nonresponders of ozanimod: 2-year interim analysis of the True North open-label extension study
S. Vermeire, J. Colombel, D. Rubin, S. Ghosh +6 more
2023Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
S734 Etrasimod 2mg Once Daily as Treatment for Patients With Moderately to Severely Active Ulcerative Colitis: Topline and Subgroup Analysis From ELEVATE UC 52 and ELEVATE UC 12
L. Peyrin-Biroulet, W. Sandborn, G. D'Haens, J. Panés +15 more
2022American Journal of Gastroenterology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Vermeire×11
Invite
S. Vermeire — researcher profile on SciRah
L. Peyrin-Biroulet×11
Invite
L. Peyrin-Biroulet — researcher profile on SciRah
W. Sandborn×10
Invite
W. Sandborn — researcher profile on SciRah
J. Panés×10
Invite
J. Panés — researcher profile on SciRah

×7

Invite

D. Wolf — researcher profile on SciRah

Jin-kun Zhang×7

Invite

Jin-kun Zhang — researcher profile on SciRah

Invite

S. Naik — researcher profile on SciRah

Invite

O. Lin — researcher profile on SciRah

Invite

B. Sands — researcher profile on SciRah

Invite

S. Danese — researcher profile on SciRah

Invite

C. Cabell — researcher profile on SciRah

Elisa K Boden×6

Invite

Elisa K Boden — researcher profile on SciRah